Component
Lung-metastasis formation in mouse breast-cancer models
Context-specific entity; species, compartment and exposure are stated on each claim.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Pharmacological inhibition of Prodh impaired lung-metastasis formation in orthotopic 4T1 and EMT6.5 mouse breast-cancer models.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Mouse breast-cancer models, complemented by three-dimensional culture and human tumor-expression comparisons.
- limitations
- This does not establish that dietary proline causes metastasis or that proline restriction is a proven treatment.
- nutrient_topic
- L-Proline collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Proline
- plain_language
- A proline-consuming pathway can support growth in a metastatic setting.
- primary_references
- Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28492237/ · DOI 10.1038/ncomms15267
L-Proline: synthesis, collagen processing, redox metabolism and cross-nutrient mechanisms (2026-09-19) · lines 382–388
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse breast-cancer models, complemented by three-dimensional culture and human tumor-expression comparisons. · source_derived_draft · unverified_draft
## l-proline-mouse-metastatic-catabolism A proline-consuming pathway can support growth in a metastatic setting. Pharmacological inhibition of Prodh impaired lung-metastasis formation in orthotopic 4T1 and EMT6.5 mouse breast-cancer models. Model: Mouse breast-cancer models, complemented by three-dimensional culture and human tumor-expression comparisons. Limitations: This does not establish that dietary proline causes metastasis or that proline restriction is a proven treatment. Evidence access: Primary abstract Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. · 2017 · https://pubmed.ncbi.nlm.nih.gov/28492237/ · DOI 10.1038/ncomms15267
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.